Remain agile" to manage costs in an uncertain global environment: Nandini Piramal

Nandini Piramal said companies must remain agile to manage costs amid global uncertainty. Piramal Pharma Ltd posted a 17 per cent revenue growth to ₹2,270 crore for the first quarter ended June 2026. The firm saw increased demand in its CDMO business as it worked to improve overall operational efficiency.